ASCENTAGE PHARMA - Trademark Details
Status: 700 - Registered
Serial Number
90039971
Registration Number
6565245
Word Mark
ASCENTAGE PHARMA
Status
700 - Registered
Status Date
2021-11-23
Filing Date
2020-07-07
Registration Number
6565245
Registration Date
2021-11-23
Mark Drawing
3000 - Illustration: Drawing or design which also includes word(s)/ letter(s)/number(s)
Typeset
Design Searches
260106 - Semi-circles.
Published for Opposition Date
2021-09-07
Attorney Name
Law Office Assigned Location Code
N50
Employee Name
LINDEMYER, ANKHI MUKHE
Statements
Indication of Colors claimed
Color is not claimed as a feature of the mark.
Disclaimer with Predetermined Text
"PHARMA"
Description of Mark
The mark consists of a stylized letter "A", in the form of an open semi-circle comprised of two lines displayed in a semi-circular manner, one of which extends at the end to form a zig-zag pattern and an additional zig-zag shaped line displayed next to such zig-zag extension, all to the left of the word "ASCENTAGE PHARMA".
Goods and Services
Medicines for dental purposes; chemical preparations for medical purposes for the treatment of cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; antibiotics; medicine for injection for the treatment of cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; medicinal tablets, for the treatment of cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; bulk drugs, namely, pharmaceutical preparations for the treatment of cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease sold in bulk; biochemical medicines for the treatment of cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; antiseptics; collyrium; suppositories being pharmaceutical preparations for the treatment of cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; plasters for medical purposes; diagnostic preparations for medical purposes; diagnostic biomarker reagents for medical purposes; medicated candy; candy for medical purposes; dietetic foods adapted for medical purposes; dietetic beverages adapted for medical purposes; dietetic preparations adapted for medical use; oil solutions, namely, medicinal oils; mineral food supplements; nutritional supplements; medicines for human purposes, namely, pharmaceutical preparations for the treatment of cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; bacterial poisons; pharmaceutical preparations for the treatment of cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; chemical-pharmaceutical preparations for the treatment of cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; drugs for medical purposes, namely, pharmaceutical preparations for the treatment of cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; biological preparations for medical purposes for the treatment of cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; chemical preparations for pharmaceutical purposes, for the treatment of cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease
Goods and Services
Analysis of the mode of action of chemical combinations on animals; scientific research for medical purposes in the area of cancerous diseases; conducting early evaluations in the field of new pharmaceuticals; pharmaceutical research services; scientific investigations for medical purposes; chemical analysis services; biochemical research and analysis; chemical research services; working on and evaluation of chemical analyses; chemical research and analysis; working on and evaluation of chemical syntheses; chemical analysis; chemistry services in the nature of chemist services; chemical research; cosmetics research; structural and functional analysis of genomes; stem cell research services; biotechnology research; blood analysis services; genetic screening for scientific research purposes; biological cloning services; research and development services in the field of antibodies; genetic testing for scientific research purposes; bacteriological research and analysis; biomedical research services; medical research; drug discovery services; medical laboratory services; development of pharmaceutical preparations and medicines; medical research services; biological research and analysis; bacteriological research; biological research; conducting clinical trials for others; computer programming in the medical field; pharmaceutical product evaluation; research on the subject of pharmaceuticals
Classification Information
International Class
005 - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes
005, 006, 018, 044, 046, 051, 052
Class Status Code
6 - Active
Class Status Date
2020-08-04
Primary Code
005
International Class
042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services. - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services.
US Class Codes
100, 101
Class Status Code
6 - Active
Class Status Date
2020-08-04
Primary Code
042
Current Trademark Owners
Party Type
30 - Original Registrant
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Trademark Owner History
Party Type
30 - Original Registrant
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Party Type
20 - Owner at Publication
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Party Type
10 - Original Applicant
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Correspondences
Name
Kelu L. Sullivan
Address
Please log in with your Justia account to see this address.
Foreign Application Information
Filing Date | Application Number | Country | Foreign Priority Claim In |
China P.Rep. | False | ||
China P.Rep. | False | ||
False |
Trademark Events
Event Date | Event Description |
2020-07-10 | NEW APPLICATION ENTERED IN TRAM |
2020-07-13 | TEAS VOLUNTARY AMENDMENT RECEIVED |
2020-07-27 | ASSIGNED TO LIE |
2020-07-27 | PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED |
2020-08-04 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
2020-08-05 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
2020-10-14 | ASSIGNED TO EXAMINER |
2020-10-20 | NON-FINAL ACTION WRITTEN |
2020-10-20 | NON-FINAL ACTION E-MAILED |
2020-10-20 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
2021-02-02 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
2021-02-03 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
2021-02-03 | TEAS/EMAIL CORRESPONDENCE ENTERED |
2021-03-23 | ASSIGNED TO EXAMINER |
2021-04-12 | FINAL REFUSAL WRITTEN |
2021-04-12 | FINAL REFUSAL E-MAILED |
2021-04-12 | NOTIFICATION OF FINAL REFUSAL EMAILED |
2021-07-28 | TEAS REQUEST FOR RECONSIDERATION RECEIVED |
2021-07-28 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
2021-07-28 | TEAS/EMAIL CORRESPONDENCE ENTERED |
2021-07-28 | APPROVED FOR PUB - PRINCIPAL REGISTER |
2021-07-30 | ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED |
2021-08-03 | ELECTRONIC RECORD REVIEW COMPLETE |
2021-08-18 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
2021-09-07 | PUBLISHED FOR OPPOSITION |
2021-09-07 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
2021-11-23 | REGISTERED-PRINCIPAL REGISTER |